Clinical trial
Natural Killer (NK) Cell Transplantation for AML
NCT00187096 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00187096 |
|---|---|
| Title | Natural Killer (NK) Cell Transplantation for AML |
| Official title | Pilot Study Of Haplo-Identical Natural Killer Cell Transplantation For Acute Myeloid Leukemia |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia |
| Intervention type | Device, Drug, Procedure |
| Interventions | Cyclophosphamide, Fludarabine, Clofarabine, Etoposide, Interleukin-2, Natural Killer Cell Infusion, CliniMACS System |
| Enrollment | 49 |
| Start date | Sep 1, 2005 |
| Primary completion | Feb 1, 2012 |
| Completion | Mar 1, 2013 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 19, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: